Allen Casey

Group Leader, High Throughput Screening/Robotics

Allen Casey joined IDRI in 2008 to manage high throughput screening for the discovery of novel inhibitors of M. tuberculosis. He is directing the automation of biochemical and cell-based assays. Allen received his bachelor's degree in Natural Science/Biology from the University of Washington. 
 
Allen has 17+ years of experience in small-molecule drug discovery in the biotech industry (Plexera, ICOS, MDS Pharma Services and Panlabs), as well as medical experience at Western Medical Center and Northwest Hospital. Formerly a technical scientist and manager at ICOS Corporation, he has expertise in high throughput screening (HTS), robotics, bioinformatics, microbiology, cell culture process development and clinical manufacturing. Allen has been creatively involved in engineering many of the instruments and software components used for drug discovery.
 
Current research activities
  • Engineering IDRI’s High Throughput Screening (HTS) center for M. tuberculosis research.
  • Development of whole cell screen for wild-type M. tuberculosis.
  • Development of AroD, LysA, PanC and Icl high-throughput assays.
  • Development of target-based whole cell screens for protease mutants of M. tuberculosis.